William Guyer, Chief Development Officer at CORCEPT THERAPEUTICS INC (CORT), sold 20,000 shares at $48.97 ($979K) on 2024-11-04, disclosed to the SEC on 2024-11-05.
Scheduled sale ($979k) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.97 | 6,606 | $323K | 33.0% |
| 2 | $48.97 | 6,606 | $323K | 33.0% |
| 3 | $48.97 | 3,394 | $166K | 17.0% |
| 4 | $48.97 | 3,394 | $166K | 17.0% |
| Total | $48.97 avg | 20,000 | $979K | 100% |
| Filing → |
| CORT | SELL | 2026-06-04 | $1.4M | — | Filing → |
| CORT | SELL | 2026-05-07 | $1.0M | — | Filing → |
| CORT | SELL | 2026-04-08 | $819K | — | Filing → |